B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

EEF2

MOLECULAR TARGET

eukaryotic translation elongation factor 2

UniProt: P13639NCBI Gene: 19381 compounds

EEF2 (eukaryotic translation elongation factor 2) is targeted by 1 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting EEF2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cycloheximide1.393

About EEF2 as a Drug Target

EEF2 (eukaryotic translation elongation factor 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 1 compounds with documented EEF2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

EEF2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.